Reading the Wegovy 2.4mg Click Chart

What the click chart is actually for, and what it isn't

Searches for the Wegovy 2.4mg click chart usually come from people who want to be certain they've set the pen correctly. That's a sensible instinct. The click chart maps the physical sensation and sound of turning the dose dial to a milligram value, so you can cross-check what you feel against what the label says. At 2.4mg, the dial is at its furthest point for the standard maintenance pen.

What the chart doesn't do is give you permission to dial past whatever dose your prescriber has written on your prescription. Every Wegovy titration step (from 0.25mg up through 0.5mg, 1mg, 1.7mg and finally 2.4mg) is clinically deliberate. The titration exists largely to reduce the gastrointestinal side effects (nausea, diarrhoea, constipation and reflux are the most common) that tend to be sharpest when the dose is new. Jumping ahead because the dial physically allows it carries real risks; jumping back without clinical guidance wastes medicine unnecessarily.

The NHS's semaglutide medicines page explains the dose schedule clearly and is worth bookmarking alongside your leaflet: NHS guidance on semaglutide. That page, combined with the printed leaflet in your pen box, is the authoritative reference for your specific pen's click count, third-party charts can lag behind pen reformulations.

Why the 2.4mg dose is the decision point most people reach

Reaching 2.4mg matters because it's the dose used in the STEP 1 trial, the phase-3 study that produced the ~15% average weight-loss figure cited in NICE's appraisal of semaglutide (TA875). Most people who tolerate the titration well arrive here after roughly four months. For some, the journey to 2.4mg is smooth; for others, the prescriber holds them at 1.7mg for an extra four weeks if side effects need more time to settle. Both are clinically normal outcomes.

The decision the click chart supports, then, is really a narrower one: have I set the pen to the right number before I inject? The broader question, am I on the right dose for me?, is one your prescriber answers at each review, using your weight trend, side-effect experience and any changes in your health since your last consultation. Those two questions are often conflated, which is why so many people land on click-chart searches when what they actually need is a clinical conversation.

If you're thinking about how 2.4mg compares to the newer 7.2mg pen or to tirzepatide at higher doses, the Wegovy doses overview covers the full licensed range and what the evidence says about each level.

Pen mechanics at 2.4mg: what you'll notice

Each Wegovy pen is pre-filled and designed so that the dose dial turns clockwise. At 2.4mg you will hear and feel the clicks accumulate as you turn; the pen stops automatically, you cannot dial past the maximum remaining dose in that pen. If there is less than 2.4mg left in a pen you've already used, the dial will stop short. That's the pen working correctly, not a fault.

The pen that arrives through a regulated UK pharmacy comes in plain, unbranded packaging (tracked to your door via DPD) and includes a full Patient Information Leaflet with a dose-setting diagram specific to that pen generation. Keep it. Novo Nordisk has updated pen formats over time, and the click count in a chart shared online may not match the pen currently in your fridge.

On the question of what the 0.25mg setting looks and feels like at the other end of the scale, the 0.25mg click chart page covers that starting-dose position in detail. If you want to understand how the 0.5mg step sits within the titration sequence, the 0.5mg click chart explains what to expect at that dial position. And if you're mid-titration and want to check the 1.7mg setting before stepping up, the 1.7mg click chart guidance is the logical next stop.

When to involve your prescriber rather than the click chart

The click chart answers one practical question. Several related questions go well beyond it, and trying to resolve them with a dial is the wrong tool entirely. Contact your prescriber (not just the chart) if: the pen won't reach 2.4mg when you believe it should be a full dose; you're experiencing side effects severe enough to make you want to drop the dose; you're wondering whether to step up to the 7.2mg pen that the MHRA approved in April 2026; or you've missed a dose and aren't sure whether to inject, skip or adjust timing. Missed doses, dose changes and switching pen formats all sit with clinical guidance and the Patient Information Leaflet, not with click counts.

A useful companion read is the full Wegovy treatment guide on this site, which covers how the medicine works, the evidence base and eligibility. For context on what private treatment costs and what an all-inclusive price actually includes, the Wegovy prices page sets that out plainly. And if the wider picture of weight-loss treatment options is useful, the treatment overview covers the licensed medicines available through nume (sorry, through a regulated UK prescribing service) alongside diet and activity support.

Our prescribers review every consultation personally. If you have questions about your current dose, your next step, or whether 2.4mg is still the right place for you to be, speaking to our prescribers is the appropriate next step, not adjusting the dial.